PEMETREXED Sandoz conc. conc perf 100 mg/4ml amp
7680665010014
CH-66501
L01BA04
07.16.1.
Reimbursement limitations:
PEMETRSA.01
Substitution préparation originale/générique
Aucune nouvelle garantie de prise en charge n'est nécessaire pour le traitement …
1 / 3
google
Details
- Product number
- 6650101
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- pemetrexedum 100.0 mg ut pemetrexedum dinatricum hemipentahydricum, natrii thiosulfas, propylenglycolum 200.0 mg, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 4 ml corresp. natrium 11.34 mg.
Articles (1)
Pemetrexed Sandoz conc. 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | ANTOX |
|
(N/A)
|
200.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
11.34 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 108.95
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/07/2021
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 66501
- Drug name
- Pemetrexed Sandoz conc., Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01BA04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 17/07/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PEMETREXED Sandoz conc. conc perf 100 mg/4ml amp
- Description (DE)
- PEMETREXED Sandoz conc. Inf Konz 100 mg/4ml Amp
- Market launch
- 17/07/2018
- Narcotic (BTM)
- No